russian BT-3Fs Were Chosen Over Ukrainian BTR-4s, But Indonesia Is Now Getting Used US AAV-7A1s Defense Express 22:48 Sat, 03 Oct
ANCA Levels and Fluorescence Patterns May Refine AAV Diagnosis Rare Disease Advisor 15:22 Fri, 02 Oct
After 14 NHL games, Ducks defence prospect signs for 6 years with $7.2M US AAV CBC.ca 02:06 Fri, 02 Oct
From Platform Knowledge to Commercial Readiness: Accelerating and De-risking your AAV Therapy's Path to Patients, Upcoming Webinar Hosted by Xtalks PR Newswire (Press Release) 13:31 Wed, 30 Sep
Cell-autonomous restoration of splicing homeostasis and RP11 phenotype in patient-derived Rpe and retinal organoids by PRPF31.AAV gene therapy Nature.com 05:10 Wed, 30 Sep
TECPR2 Research Foundation and Forge Biologics Announce AAV Development and Manufacturing Partnership to Advance Gene Therapy for TECPR2 Business Wire (Press Release) 13:09 Tue, 29 Sep
Minaris, Asimov Partner on AAV Gene Therapy Manufacturing American Pharmaceutical Outsourcing (Press Release) 16:29 Mon, 28 Sep
Plasma Exchange May Reduce Disease Activity in Severe Pediatric AAV Rare Disease Advisor 18:07 Thu, 24 Sep
AAV Subtypes Carry High CV, Thromboembolic Risks, With Sex-Specific Variations Rare Disease Advisor 17:05 Thu, 24 Sep
Minaris and Asimov Partner to Advance AAV Manufacturing with Oxgene Technology PR Newswire (Press Release) 13:04 Thu, 24 Sep
Rare Case Study: MPA Subtype of MPO-AAV With Severe Pulmonary-Renal Relapse Renal and Urology News 15:18 Fri, 18 Sep
Rituximab Similar to Cyclophosphamide in AAV With Kidney Involvement Rare Disease Advisor 15:19 Thu, 17 Sep
Devils Sign Luke Evangelista to 5-Year, $36.25M ($7.25M AAV) Contract Extension All About The Jersey 08:31 Wed, 16 Sep
Subgroup of Relapsing Patients With AAV Show Suboptimal Rituximab Response Renal and Urology News 15:19 Tue, 15 Sep
Canadiens sign forward Zachary Bolduc to four-year deal with US$4.2 million AAV CTV News Montreal 19:32 Mon, 14 Sep
Post-PLEX LDH/Lymphocyte Ratio Signals Mortality Risk in AAV Renal and Urology News 15:18 Wed, 09 Sep
EpilepsyGTx et Viralgen collaborent pour faire progresser le programme de thérapie génique à base d'AAV contre l'épilepsie, en vue d'un premier essai clinique chez l'humain PR Newswire (Press Release) 13:52 Wed, 09 Sep
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy Pharmaceutical Field 12:46 Wed, 09 Sep
Bayer AG: AskBio's Viralgen,EpilepsyGTx Partner To Advance AAV Gene Therapy For Epilepsy RTT News 12:38 Wed, 09 Sep
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy program for epilepsy ahead of first-in-human trial News-Medical.Net 12:27 Wed, 09 Sep
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial PR Newswire (Press Release) 09:07 Wed, 09 Sep